Oxford Biodynamics Plc Stock Performance
| OXBOF Stock | USD 0.02 0.00 0.00% |
The company holds a Beta of 1.21, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Oxford BioDynamics will likely underperform. At this point, Oxford BioDynamics Plc has a negative expected return of -1.91%. Please make sure to check Oxford BioDynamics' coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and rate of daily change , to decide if Oxford BioDynamics Plc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Oxford BioDynamics Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 2.2 M | |
| Free Cash Flow | -6.1 M |
Oxford |
Oxford BioDynamics Relative Risk vs. Return Landscape
If you would invest 15.00 in Oxford BioDynamics Plc on August 30, 2024 and sell it today you would lose (12.90) from holding Oxford BioDynamics Plc or give up 86.0% of portfolio value over 90 days. Oxford BioDynamics Plc is currently producing negative expected returns and takes up 11.1382% volatility of returns over 90 trading days. Put another way, 99% of traded pink sheets are less volatile than Oxford, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Oxford BioDynamics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oxford BioDynamics' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Oxford BioDynamics Plc, and traders can use it to determine the average amount a Oxford BioDynamics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1714
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OXBOF |
Estimated Market Risk
| 11.14 actual daily | 96 96% of assets are less volatile |
Expected Return
| -1.91 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Oxford BioDynamics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oxford BioDynamics by adding Oxford BioDynamics to a well-diversified portfolio.
Oxford BioDynamics Fundamentals Growth
Oxford Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Oxford BioDynamics, and Oxford BioDynamics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Oxford Pink Sheet performance.
| Return On Equity | -1.45 | |||
| Return On Asset | -0.4 | |||
| Operating Margin | (55.85) % | |||
| Current Valuation | 37.52 M | |||
| Shares Outstanding | 146.71 M | |||
| Price To Book | 0.19 X | |||
| Price To Sales | 198.91 X | |||
| Revenue | 154 K | |||
| EBITDA | (6.16 M) | |||
| Cash And Equivalents | 4.59 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 6.46 M | |||
| Debt To Equity | 0.99 % | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (5.18 M) | |||
| Earnings Per Share | (0.09) X | |||
| Total Asset | 11.34 M | |||
About Oxford BioDynamics Performance
By analyzing Oxford BioDynamics' fundamental ratios, stakeholders can gain valuable insights into Oxford BioDynamics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Oxford BioDynamics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Oxford BioDynamics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom. Oxford Biodynamics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 44 people.Things to note about Oxford BioDynamics Plc performance evaluation
Checking the ongoing alerts about Oxford BioDynamics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Oxford BioDynamics Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Oxford BioDynamics generated a negative expected return over the last 90 days | |
| Oxford BioDynamics has high historical volatility and very poor performance | |
| Oxford BioDynamics has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 154 K. Net Loss for the year was (6.71 M) with profit before overhead, payroll, taxes, and interest of 116 K. | |
| Oxford BioDynamics Plc has accumulated about 4.59 M in cash with (5.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 31.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Oxford BioDynamics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Oxford BioDynamics' stock is overvalued or undervalued compared to its peers.
- Examining Oxford BioDynamics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Oxford BioDynamics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Oxford BioDynamics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Oxford BioDynamics' pink sheet. These opinions can provide insight into Oxford BioDynamics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Oxford Pink Sheet analysis
When running Oxford BioDynamics' price analysis, check to measure Oxford BioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oxford BioDynamics is operating at the current time. Most of Oxford BioDynamics' value examination focuses on studying past and present price action to predict the probability of Oxford BioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oxford BioDynamics' price. Additionally, you may evaluate how the addition of Oxford BioDynamics to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |